Novo Nordisk A/S (ADR) (NYSE:NVO)

CAPS Rating: 4 out of 5

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

Recs

0
Player Avatar Henrikow (< 20) Submitted: 8/9/2012 2:46:41 AM : Outperform Start Price: $154.53 NVO Score: -8.70

One of the best pipelines in the industry

Featured Broker Partners


Advertisement